BDO USA, LLP invites you and your colleagues to a complimentary CPE-qualified webinar on how changes in healthcare reimbursement are reshaping the healthcare landscape for biotechnology companies.
 
This webinar will:

• Explain the impact of recent changes in reimbursement and how health systems are adopting new business models regarding pricing profitability
• Introduce the concept of value-based delivery for drugs
• Explain how improved outcomes and lower administration costs create more value

Who should attend? CEOs, CFOs, Chief Clinical Officers, Chief Medical Officers, or anyone else responsible for new biotechnology discoveries or administering drug therapies in the community